Home > Insider Trading > Filing (0001181431-10-035797)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Sunesis Pharmaceuticals Inc	SNSS	Pharmaceutical Preparations (2834)	943295878

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1005544	Iii W Charles Newhall	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1005550	Richard C Kramlich	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1005561	J Peter Barris	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1062466	W Mark Perry	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1219855	James M Barrett	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1237289	D Scott Sandell	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1383389	Nea 12 Gp, Llc	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1383390	Nea Partners 12, Limited Partnership	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1383391	New Enterprise Associates 12, Limited Partnership	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1448784	Growth Equity Opportunities Fund, Llc	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-06-30	23,824,451	$0.28	23,824,451	No	4	P	Direct
Common Stock	Acquisiton	2010-06-30	9,994,990	$0.00	33,819,441	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	C	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2010-06-30	999,499	$0.00	9,994,990	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

The securities are directly held by Growth Equity Opportunities Fund, LLC ("GEO") and indirectly held by New Enterprise Associates 12, Limited Partnership ("NEA 12"), the sole member of GEO, NEA Partners 12, Limited Partnership ("NEA Partners 12"), the sole general partner of NEA 12, NEA 12 GP, LLC ("NEA 12 GP"), the sole general partner of NEA Partners 12, and the individual managers of NEA 12 GP (NEA 12, NEA Partners 12, NEA 12 GP and the individual managers of NEA 12 GP, together, the "Indirect Reporting Persons").
The individual managers of NEA 12 GP are M. James Barrett, Peter J. Barris, Forest Baskett, Ryan D. Drant, Patrick J. Kerins, C. Richard Kramlich, Krishna "Kittu" Kolluri, Charles W. Newhall, III, Mark W. Perry and Scott D. Sandell. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the "1934 Act"), or otherwise of the securities of the issuer held by GEO, except to the extent of such Indirect Reporting Person's pecuniary interest therein, if any.
Each one (1) share of Series A Preferred Stock was converted into ten (10) shares of Common Stock upon the issuer's common equity closing (as defined in the applicable Certificate of Designation). The Series A Perferred Stock had no expiration date.